Press Releases

Parenteral Nutrition Market is Anticipated to Grow US$ 11.4 Bn By 2030

The global Parenteral Nutrition market size is expected to reach USD 11.4 billion by 2030 and is expected to expand at a CAGR of 10.8% from 2021 to 2030.

Download Exclusive Sample of Report@

Growth Factors

 The growing burden of chronic diseases, such as diabetes, cancer, and other neurological conditions, increasing deficiency of essential nutrients among critically ill patients, and the growing awareness regarding hospital-related malnutrition are some of the major factors driving the adoption of parenteral nutrition. Parenteral nutrition (PN) plays a vital role in supporting better health outcomes as malnutrition can have a serious impact on hospitalized patients. Hospitalized adults diagnosed with malnutrition have a longer length of hospital stay and higher recovery costs and are five times more likely to die compared to other adult inpatients.

The consumption of fat emulsions as part of PN has significantly increased among preterm neonates in their initial life after birth owing to their intolerance to full enteral nutrition and benefits of parenteral nutrition that provides a relatively safe means for preventing nutritional deficiency. A research article published in Eastern Mediterranean Health Journal in 2017 reported that the prevalence of malnutrition among hospitalized infants and children in various countries ranged between 6.1% and 40.9%. Intravenous lipid emulsions (ILEs) are an essential component of PN, majorly in preterm and very-low-birth infants as these formulations have revolutionized the management of infants suffering from gastrointestinal (GI) anomalies and other conditions, including intestinal failure, by providing nutritional support for intestinal growth.

Report Highlights

single-dose amino acid solution accounted for the largest share of 41.0%. This is attributed to the adoption of these products, along with vitamins, dextrose, and trace minerals, for maintaining weight equilibrium among the undernourished population.

North America accounted for the largest share of 41.7% in 2020. This can be attributed to the availability of technologically advanced medical devices, high research expenditure by government agencies and private entities in the healthcare sector, and collaborations among universities, regulatory authorities, and the medical device industry. Increasing demand for home health care products is one of the major drivers for this market as PN products are available in clinical care and home health care.

Report Coverage Details
Market Size US$ 11.4 billion by 2030
Growth Rate CAGR of 10.8% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Nutrient type
Regional Scope North America, Latin America, Europe, Asia Pacific, MEA
Companies Mentioned Baxter; Grifols, S.A.; Allergan; Otsuka Pharmaceutical Factory, Inc.; Actavis Inc.; B. Braun Melsungen AG; Fresenius Kabi AG; ViforPharma; Sichuan Kelun Pharmaceutical Co., Ltd.; Pfizer Inc. (Hospira Inc.)

Key Players

  • Baxter
  • Grifols, S.A.
  •  Allergan
  • Otsuka Pharmaceutical Factory, Inc.
  • Actavis Inc.
  • B. Braun Melsungen AG
  •  Fresenius Kabi AG
  • ViforPharma
  •  Sichuan Kelun Pharmaceutical Co., Ltd.
  •  Pfizer Inc. (Hospira Inc.)

Market Segmentation

  • Nutrient Type Outlook
    • Carbohydrates
    • Parenteral Lipid Emulsion
    • Single Dose Amino Acid Solution
    • Trace Elements
    • Vitamins & Minerals
  • Regional Outlook
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • Spain
      • Italy
      • France
    • Asia Pacific
      • Japan
      • China
      • India
      • Thailand
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
    • MEA
      • South Africa
      • Saudi Arabia
      • UAE

Buy this Research Report study@

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape        List of Suppliers        List of Buyers

Chapter 7.  Global Parenteral Nutrition Market, By Nutrient Type

7.1.  Parenteral Nutrition Market, by Nutrient Type, 2020-2027

7.1.1.    Carbohydrates        Market Revenue and Forecast (2016-2027)

7.1.2.    Parenteral Lipid Emulsion        Market Revenue and Forecast (2016-2027)

7.1.3.    Single Dose Amino Acid Solution        Market Revenue and Forecast (2016-2027)

7.1.4.    Trace Elements        Market Revenue and Forecast (2016-2027)

7.1.5.    Vitamins & Minerals        Market Revenue and Forecast (2016-2027)

Chapter 8.  Global Parenteral Nutrition Market, Regional Estimates and Trend Forecast

8.1.  North America

8.1.1.    Market Revenue and Forecast, by Nutrient Type (2016-2027)

8.1.2.    U.S.

8.1.3.    Rest of North America        Market Revenue and Forecast, by Nutrient Type (2016-2027)

8.2.  Europe

8.2.1.    Market Revenue and Forecast, by Nutrient Type (2016-2027)

8.2.2.    UK        Market Revenue and Forecast, by Nutrient Type (2016-2027)

8.2.3.    France        Market Revenue and Forecast, by Nutrient Type (2016-2027)

8.2.4.    Rest of Europe        Market Revenue and Forecast, by Nutrient Type (2016-2027)

8.3.  APAC

8.3.1.    Market Revenue and Forecast, by Nutrient Type (2016-2027)

8.3.2.    India        Market Revenue and Forecast, by Nutrient Type (2016-2027)

8.3.3.    China        Market Revenue and Forecast, by Nutrient Type (2016-2027)

8.3.4.    Japan        Market Revenue and Forecast, by Nutrient Type (2016-2027)

8.3.5.    Rest of APAC        Market Revenue and Forecast, by Nutrient Type (2016-2027)

8.4.  MEA

8.4.1.    Market Revenue and Forecast, by Nutrient Type (2016-2027)

8.4.2.    GCC        Market Revenue and Forecast, by Nutrient Type (2016-2027)

8.4.3.    North Africa        Market Revenue and Forecast, by Nutrient Type (2016-2027)

8.4.4.    South Africa        Market Revenue and Forecast, by Nutrient Type (2016-2027)

8.4.5.    Rest of MEA        Market Revenue and Forecast, by Nutrient Type (2016-2027)

8.5.  Latin America

8.5.1.    Market Revenue and Forecast, by Nutrient Type (2016-2027)

8.5.2.    Brazil        Market Revenue and Forecast, by Nutrient Type (2016-2027)

8.5.3.    Rest of LATAM        Market Revenue and Forecast, by Nutrient Type (2016-2027)

Chapter 9.    Company Profiles

9.1.  Baxter

9.1.1.    Company Overview

9.1.2.    Product Offerings

9.1.3.    Financial Performance

9.1.4.    Recent Initiatives

9.2.  Grifols, S.A.

9.2.1.    Company Overview

9.2.2.    Product Offerings

9.2.3.    Financial Performance

9.2.4.    Recent Initiatives

9.3.  Allergan

9.3.1.    Company Overview

9.3.2.    Product Offerings

9.3.3.    Financial Performance

9.3.4.    Recent Initiatives

9.4.  Otsuka Pharmaceutical Factory, Inc.

9.4.1.    Company Overview

9.4.2.    Product Offerings

9.4.3.    Financial Performance

9.4.4.    Recent Initiatives

9.5.  Actavis Inc.

9.5.1.    Company Overview

9.5.2.    Product Offerings

9.5.3.    Financial Performance

9.5.4.    Recent Initiatives

9.6.  B. Braun Melsungen AG

9.6.1.    Company Overview

9.6.2.    Product Offerings

9.6.3.    Financial Performance

9.6.4.    Recent Initiatives

9.7.  Fresenius Kabi AG

9.7.1.    Company Overview

9.7.2.    Product Offerings

9.7.3.    Financial Performance

9.7.4.    Recent Initiatives

9.8.  ViforPharma

9.8.1.    Company Overview

9.8.2.    Product Offerings

9.8.3.    Financial Performance

9.8.4.    Recent Initiatives

9.9.  Sichuan Kelun Pharmaceutical Co., Ltd.

9.9.1.    Company Overview

9.9.2.    Product Offerings

9.9.3.    Financial Performance

9.9.4.    Recent Initiatives

9.10.              Pfizer Inc. (Hospira Inc.)

9.10.1.  Company Overview

9.10.2.  Product Offerings

9.10.3.  Financial Performance

9.10.4.  Recent Initiatives

Chapter 10.  Research Methodology

10.1.              Primary Research

10.2.              Secondary Research

10.3.              Assumptions

Chapter 11.  Appendix

11.1.              About Us

Glossary of Terms

Buy this Research Report study@

Contact Us:

Vision Research Reports

Call: +1 9197 992 333


Show More

Related Articles

Back to top button